Antiretroviral Concentration in Hair As a Measure for Antiretroviral Medication Adherence: A Systematic Review of Global Literature

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2019 Mar 17

PMID 30877582

Citations 10

Authors

Quan Zhang

Shan Qiao

Xueying Yang

Xiaoming Li

Affiliations

Soon will be listed here.

Abstract

This review aims to validate hair antiretroviral concentration (HAC) as a measure for antiretroviral medication adherence. This review included 31 studies that analyzed a total of 11 ARV drugs in four different drug classes. The associations between HAC and non-pharmacokinetic measures were generally lower than the association between HAC and other pharmacokinetic measures: the correlation coefficients (r) ranged from - 0.20 to 0.38 for self-report or pill counts and 0.20 to 0.85 for electronic drug monitoring; HAC and other pharmacokinetic measures were positively correlated with the correlation coefficients (r) ranging from 0.20 to 0.72, 0.34 to 0.86, 0.50 to 0.85 for antiretroviral concentration in plasma, peripheral blood mononuclear cells, and dried blood spots, respectively. HAC was one of the strongest independent predictors of virologic responses. HAC of tenofovir was significantly associated with renal toxicity in large sample studies. This review suggests that HAC is a valid biomarker of antiretroviral medication adherence.

Citing Articles

Detection of Antiretrovirals in Transgender Women With HIV Is Not Altered by Hair Treatments.

Rodriguez V, Alcaide M, Sued O, Aristegui I, Radusky P, Kozlova S J Acquir Immune Defic Syndr. 2023; 94(3):e3-e5.

PMID: 37850983 PMC: 10593490. DOI: 10.1097/QAI.0000000000003275.

Measurement Tools and Utility of Hair Analysis for Screening Adherence to Antihypertensive Medication.

Sharma J, Dludla P, Dwivedi G, Johnson R Glob Heart. 2023; 18(1):17.

PMID: 36968302 PMC: 10038111. DOI: 10.5334/gh.1191.

A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children.

Yin D, Cole S, Ludema C, Brookhart M, Golin C, Miller W Am J Epidemiol. 2023; 192(6):916-928.

PMID: 36896583 PMC: 10505414. DOI: 10.1093/aje/kwad054.

Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China.

Wu Y, Liu S, Chu L, Zhang Q, Yang J, Qiao S Patient Prefer Adherence. 2022; 16:1885-1896.

PMID: 35945983 PMC: 9357394. DOI: 10.2147/PPA.S371623.

Clinical Value of Emerging Bioanalytical Methods for Drug Measurements: A Scoping Review of Their Applicability for Medication Adherence and Therapeutic Drug Monitoring.

Zijp T, Izzah Z, Aberg C, Gan C, Bakker S, Touw D Drugs. 2021; 81(17):1983-2002.

PMID: 34724175 PMC: 8559140. DOI: 10.1007/s40265-021-01618-7.

References

Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo H, Haas D . Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. Clin Infect Dis. 2018; 68(6):1044-1047. PMC: 6399433. DOI: 10.1093/cid/ciy764. View

Gandhi M, Glidden D, Liu A, Anderson P, Horng H, Defechereux P . Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring. J Infect Dis. 2015; 212(9):1402-6. PMC: 4601920. DOI: 10.1093/infdis/jiv239. View

Huang Y, Gandhi M, Greenblatt R, Gee W, Lin E, Messenkoff N . Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008; 22(21):3401-9. PMC: 2669487. DOI: 10.1002/rcm.3750. View

van Zyl G, van Mens T, McIlleron H, Zeier M, Nachega J, Decloedt E . Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr. 2011; 56(4):333-9. PMC: 3073814. DOI: 10.1097/QAI.0b013e31820dc0cc. View

Duval X, Peytavin G, Breton G, Ecobichon J, Descamps D, Thabut G . Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination. AIDS. 2006; 21(1):106-8. DOI: 10.1097/QAD.0b013e3280118486. View

Gandhi M, Murnane P, Bacchetti P, Elion R, Kolber M, Cohen S . Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS. 2017; 31(16):2245-2251. PMC: 5633521. DOI: 10.1097/QAD.0000000000001615. View

Seifert S, Castillo-Mancilla J, Erlandson K, Morrow M, Gandhi M, Kuncze K . Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy. J Acquir Immune Defic Syndr. 2017; 77(3):295-298. PMC: 5807216. DOI: 10.1097/QAI.0000000000001596. View

Berg K, Arnsten J . Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006; 43 Suppl 1:S79-87. PMC: 2866146. DOI: 10.1097/01.qai.0000248337.97814.66. View

Baxi S, Liu A, Bacchetti P, Mutua G, Sanders E, Kibengo F . Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr. 2014; 68(1):13-20. PMC: 4262724. DOI: 10.1097/QAI.0000000000000386. View

10.

Podsadecki T, Vrijens B, Tousset E, Rode R, Hanna G . "White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials. 2008; 9(4):238-46. DOI: 10.1310/hct0904-238. View

11.

Gandhi M, Greenblatt R, Bacchetti P, Jin C, Huang Y, Anastos K . A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. J Infect Dis. 2012; 206(9):1453-61. PMC: 3466997. DOI: 10.1093/infdis/jis508. View

12.

Castillo-Mancilla J, Haberer J . Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring. Curr HIV/AIDS Rep. 2018; 15(1):49-59. PMC: 5876155. DOI: 10.1007/s11904-018-0377-0. View

13.

Rohrich C, Drogemoller B, Ikediobi O, van der Merwe L, Grobbelaar N, Wright G . CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women. AIDS Res Hum Retroviruses. 2015; 32(6):529-38. PMC: 4892230. DOI: 10.1089/AID.2015.0048. View

14.

Pintye J, Bacchetti P, Teeraananchai S, Kerr S, Prasitsuebsai W, Singtoroj T . Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017; 76(4):367-371. PMC: 5659884. DOI: 10.1097/QAI.0000000000001527. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

16.

Castillo-Mancilla J, Zheng J, Rower J, Meditz A, Gardner E, Predhomme J . Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2012; 29(2):384-90. PMC: 3552442. DOI: 10.1089/AID.2012.0089. View

17.

Chu L, Wu Y, Duan C, Yang J, Yang H, Xie Y . Simultaneous quantitation of zidovudine, efavirenz, lopinavir and ritonavir in human hair by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1097-1098:54-63. DOI: 10.1016/j.jchromb.2018.08.031. View

18.

Gandhi M, Greenblatt R . Hair it is: the long and short of monitoring antiretroviral treatment. Ann Intern Med. 2002; 137(8):696-7. DOI: 10.7326/0003-4819-137-8-200210150-00016. View

19.

Koss C, Bacchetti P, Hillier S, Livant E, Horng H, Mgodi N . Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Res Hum Retroviruses. 2017; 33(8):778-783. PMC: 5564054. DOI: 10.1089/aid.2016.0202. View

20.

Baxi S, Greenblatt R, Bacchetti P, Jin C, French A, Keller M . Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients. PLoS One. 2015; 10(6):e0129100. PMC: 4460031. DOI: 10.1371/journal.pone.0129100. View